SR One Summit 2025 Agenda & Attendees
The Next Frontier of Medicine: Five Years of Innovation Leadership
The Dolder Grand, Kurhausstrasse 65, 8032 Zürich, Switzerland
October 7-8, 2025
Tuesday, October 7th
6:00pm - 8:30pm
Welcome Reception, Restaurant Adlisberg, Adlisbergstrasse 75, 8044 Zurich, Switzerland
An intimate evening to connect with fellow innovation leaders while overlooking the Swiss countryside. Join SR One's portfolio CEOs, pharmaceutical executives, and investment partners for curated conversations on the forces reshaping our industry. A surprise guest — acclaimed actor, musician and producer whose groundbreaking performances and social impact have earned global recognition — will join us for an exclusive fireside chat.
Wednesday, October 8th
8:30am - 1:00pm | SR One Summit Sessions, The Ballroom, The Dolder Grand
8:00am - 8:30am
Executive Breakfast, The Ballroom Foyer, The Dolder Grand
8:30am - 8:40am (10)
Opening Remark | Five Years Forward: SR One's Journey and the Road Ahead
Simeon George, MD, CEO & Managing Partner, SR One
8:40am - 9:10am (30)
Fireside Chat | "Gene Editing's Next Chapter: From Nobel Prize to Patient Impact"
The Nobel Laureate who co-invented CRISPR/Cas9 joins the former CEO transforming the technology into life-saving therapies for an unprecedented conversation on scientific breakthrough and commercial reality.
Speakers:
Emmanuelle Charpentier, PhD, Nobel Laureate, Co-inventor of CRISPR/Cas9
Rodger Novak, MD, Founding CEO, CRISPR Therapeutics
Simeon George, MD, CEO & Managing Partner, SR One
Moderator: Iqbal Mufti, Venture Partner, SR One
9:10am - 9:55am (45)
Innovation Spotlights Part I | "Portfolio Pioneers: Building the Next Wave"
Rapid-fire presentations from SR One portfolio companies developing breakthrough therapies across oncology, rare diseases, and beyond. Interactive Q&A with audience.
Featured Portfolio Companies:
Daanish Jamal, CEO, Dolomite Therapeutics
Derek Hicks, CEO, Rezo Therapeutics
Ronald Park, MD, CEO, Addition Therapeutics
Milad Dagher, CEO, Nomic Bio
Eliot Charles, PhD, CEO, Codify Therapeutics
Moderator: Matthew Harrison, Managing Director, Healthcare Investment Banking, Morgan Stanley
9:55am - 10:30am (35)
Research & Development Leadership Panel | "R&D at a Crossroads: Navigating Innovation, Risk, and Speed in a New Biotech Cycle"
Global R&D leaders discuss how pharma is adapting its innovation model—what's changing in scientific decision-making, how pipelines are being reshaped, and where collaboration with biotech is most critical.
Panelists:
Christian Rommel, PhD, Global Head of Research and Development, Pharmaceuticals Division, Bayer
David M. Lee, MD, PhD, SVP, Global Immunology Therapeutic Area Head, Johnson & Johnson Innovative Medicine
Shreeram Aradhye, MD, President, Global Development and Chief Medical Officer, Novartis
Karin Conde-Knape, Former SVP Early Development, Novo
Moderator: Simon Elliott, Senior Managing Director, Healthcare Strategic Advisory, Evercore
10:30am - 11:00am (30)
Networking Break, The Ballroom Foyer, The Dolder Grand
11:00am - 11:35am (35)
Case Study: Two Paths to Strategic Partnership | "Behind the Billion-Dollar Deals: ADARx-AbbVie & Dren Bio-Sanofi"
A behind-the-scenes look at two of 2025's most significant strategic deals — ADARx with AbbVie and Dren Bio with Sanofi. CEOs from both companies share how distinct platforms, clear execution, and smart syndicates led to multi-billion-dollar partnerships.
Panelists:
Zhen Li, PhD President & CEO, ADARx Pharmaceuticals
Nenad Tomasevic, PhD CEO & Founder, Dren Bio
Michael Palladinetti, Global Head of Business Development and Licensing, Sanofi
Rajeev Dadoo, PhD, COO & Managing Partner, SR One
Amit Shah, MD, Principal, SR One
Moderator: Dan Koeppen, Partner, Wilson Sonsini
11:35am - 12:20pm (45)
Innovation Spotlights Part II | "Portfolio Pioneers: Translating Innovation to Clinical Impact”
Rapid-fire presentations from SR One portfolio companies developing breakthrough therapies across oncology, rare diseases, and beyond. Interactive Q&A with audience.
Featured Portfolio Companies:
Athena Countouriotis, MD, CEO, Avenzo Therapeutics
James Mackay, PhD, CEO, Crystalys Therapeutics
Joerg Mueller, MD, PhD, CEO, Antag Therapeutics
Sanuj Ravindran, MD, CEO, Simcha Therapeutics
Jacob Chacko, MD, CEO, ORIC Pharma
Moderator: Laetitia Schwab, PhD, Senior Associate, SR One
12:20pm - 12:55pm (35)
Business Development Leadership Panel | "What's on the Radar: BD Leaders on Deal Flow, Priorities & Partnering Trends"
Pharma's top BD leaders share their views on where innovation is most needed, how internal priorities are shifting, and what it now takes for biotech to stand out. From deal structures to modality focus, this conversation will surface the signals that matter most in today's partnering landscape.
Panelists:
Chris Sheldon, PhD, SVP, Global Head of Business Development, GSK
Ronny Gal, PhD, Chief Strategy & Growth Officer, Novartis
Avaleigh Milne, Global Head of Business Development Strategy & Practice, Roche
Moderator: Iqbal Mufti, Venture Partner, SR One
12:55pm - 1:00pm (5)
Closing Remarks
Simeon George, MD, CEO & Managing Partner, SR One
1:00pm - 3:00pm
Networking Lunch, The Ballroom Foyer, The Dolder Grand
Continue conversations from the morning sessions while connecting with fellow executives, investors, and innovators over a curated lunch experience
Participants
BioPharma
Sergio Capancioni, PhD
Director Search and Evaluation, International, AbbVie
Duncan Young, PhD
Executive Director, Oncology Business Development, AstraZeneca
Greg Rossi, PhD
SVP, Oncology Europe and Canada, AstraZeneca
Hiroyuki Usuda, PhD
Scouting & Transaction Lead, Business Development, Astellas
Christian Rommel, PhD
Global Head of Research & Development, Bayer
Yves Wyckmans
Senior Director, International Business Development & External Innovation, Biogen
Piyush Durani, MD
Executive Director, Global Business Development, BMS
Anne Witt, PhD
Enterprise Head of Strategy & Corporate Development, CSL
Chris Sheldon, PhD
SVP, Global Head Business Development, GSK
Jeremy Quirk, PhD
VP, Business Development & Licensing Commercial Portfolio, GSK
Kaivan Khavandi, PhD
SVP, Head of R&D, Respiratory, Immunology & Inflammation, GSK
David M. Lee, MD, PhD
SVP, Global Immunology Therapeutic Area Head, Johnson & Johson
Sonal Patel
VP, Oncology Scientific Innovation, Johnson & Johnson
Ronny Gal, PhD
Chief Strategy & Growth Officer, Novartis
Susanne Kreutz, PhD
Global Head of Corporate & Business Development, Novartis
Shreeram Aradhye, MD
President, Development and Chief Medical Officer, Novartis
Richard Siegel, MD, PhD
Global Head, Immunology, Biomedical Research, Novartis
Markus Werner, PhD
Head Search & Evaluation Oncology, Novartis
Rico Funhoff, PhD
Director, S&E Corporate & Business Development, Novartis
Karin Conde-Knape, PhD
Former SVP Early Development, Novo Nordisk
Avaleigh Milne
Global Head of Business Development Strategy & Practice, Roche
Fabian Birzele, PhD
Global Head Computational Biology & Medicine, Roche
Kara Lassen, PhD
SVP, Global Head Cardiovascular, Metabolism and Immunology, Roche
Sylke Poehling, PhD
SVP, Global Head, Therapeutic Modalities, Pharma Research & Early Development, Roche
Michael Palladinetti
Global Head of Business Development and Licensing, Sanofi
Portfolio Companies
Ben Buelow
CEO, 92Bio
Zhen Li, PhD
President & CEO, ADARx Pharmaceuticals
Ronald Park, MD
CEO, Addition Therapeutics
Joerg Moeller, MD, PhD
CEO, Antag Therapeutics
Athena Countouriotis, MD
Co-founder & CEO, Avenzo Therapeutics
Scott Lipman
Chief Business Officer, Avenzo Therapeutics
Lyn Baranowski
CEO, Avalyn Pharma
Leah Fung, PhD
CEO, Biotheryx
Pratik Shah, PhD
Co-founder & CEO, Design Therapeutics and Chair of Board, ARS Pharma
Eliot Charles, PhD
CEO, Codify Therapeutics
James Mackay, PhD
President & CEO, Crystalys Therapeutics
Daanish Jamal
Founder & CEO, Dolomite Therapeutics
Nenad Tomasevic, PhD
CEO & Founder, Dren Bio
Owen Wallace, PhD
CEO, Econic Bio
Chase Coffman, PhD
CEO, Elektrofi
Jonathan Montagu
CEO, HotSpot Therapeutics
Jon Congleton
CEO, Mineralys Therapeutics
Abbas Kazimi, MS
CEO, Nimbus Therapeutics
Nadir Mahmood, PhD
President, Nkarta
Milad Dagher, PhD
CEO, Nomic Bio
Gary Glick, PhD
Founder & CEO Odyssey Therapeutics and Chairman of Charm Therapeutics
Jim Broderick, MD
CEO & Founder, Palleon Pharmaceuticals
Jacob Chacko, MD
CEO, ORIC Pharmaceuticals
Rene van der Merwek, MBChB
Chief Medical Officer, Phylaxis Bioscience
Dan Burgess
Chairman & CEO, Pulmocide
BT Slingsby, PhD
Representative Director, CEO & Co-founder, Renalys Pharma
Derek Hicks
CEO, Rezo Therapeutics
Sanuj Ravindran, MD
CEO, Simcha Therapeutics
Magdalene Moran, PhD
CEO, Topo Therapeutics
Reid Waldman, MD
CEO, VeraDermics
Luca Santarelli, MD
CEO, Winward Bio
Rodger Novak, MD
CEO, Xap Therapeutics and Board Chair, Econic Biosciences
Sponsors and Guests
Emmanuelle Charpentier, PhD
Nobel Laureate, Co-inventor of CRISPR/Cas9
Francois Maisonrouge
Senior Managing Director, Healthcare Strategic Advisory, Evercore
Simon Elliott
Senior Managing Director, Healthcare Strategic Advisory, Evercore
Israel Akinrinsola
Director Global Healthcare Investment Banking, Evercore
Michael White
Head of Life Sciences, UK & Nordic, HSBC
Jamie Bignal
Director, Life Sciences, HSBC Innovation Bank
Ryuk Byun, MD
Managing Director, Healthcare Investment Banking, Morgan Stanley
David Haber
Managing Director, Healthcare Investment Banking, Morgan Stanley
Matthew Harrison
Managing Director, Healthcare Investment Banking, Morgan Stanley
Cailin McGurk, MD
Co-Head Global Biopharma, Managing Director,
Healthcare Investment Banking, Morgan Stanley
Niren Thanky, PhD
Partner & Head of Healthcare EMEA, Spencer Stuart
Monisha Banerjee, PhD
Partner, Healthcare & Board Practices, Spencer Stuart
Misha Wolfe
Partner, Spencer Stuart
Lisa Flavin
Consultant, Biopharma and Board Practice, Spencer Stuart
Dan Koeppen
Partner, Wilson Sonsini
Michael Hostetler
Patent Partner, Wilson Sonsini
Kassandra Castillo
Corporate Partner, Wilson Sonsini
Dr. Norm Hovijitra
Partner, Technology Transactions, Wilson Sonsini
SR One
Alicia Hasson
Executive Assistant, SR One
Amit Shah, MD
Principal, SR One
Amit Mehta, PhD
COO & CBO, Dren Bio and Venture Partner, SR One
Briana Wilson
Senior Administrative Assistant, SR One
Ann Ng
Finance Controller, SR One
Catalina Kazi
Compliance & Legal Counsel, SR One
Chris Chai
Venture Partner, SR One
Frances Benson
Chief of Staff, SR One
Iqbal Mufti
Venture Partner, SR One
Jake Bauer
Venture Partner, SR One
Jake Nunn
Partner, SR One
Jill Carroll
Partner, SR One
Janet Mastrocola
Executive Assistant, SR One
James Macadam
CFO, SR One
Katarina Pance, PhD
Senior Associate, SR One
Karen Narolewski Engel
Vice President Operations, SR One
Laetitia Scwhab, PhD
Senior Associate, SR One
Lyla Youssef, PhD
Associate, SR One
Mahesh Kudari, MD
Senior Associate, SR One
Mary Mirt
Administrative Assistant, SR One
Matthew Patterson
Venture Partner, SR One
Philip Habib
Head of Capital Partnering, SR One
Rajeev Dadoo, PhD
COO & Managing Partner, SR One
Sasha Keough
General Counsel & Chief Compliance Officer, SR One
Simeon George, MD
CEO & Managing Partner, SR One
Tanya McGlashan
Manager, UK Operations, SR One
Viraj Pillai
Finance Controller, SR One